Treatment as Prevention for Hepatitis C in Iceland. A Nationwide Campaign for Reducing Disease Burden Using Combination Antiviral Treatment
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.
Locations
Other Locations
Iceland
Landspitali
RECRUITING
Reykjavik
Contact Information
Primary
Ragnheidur Fridriksdottir, B.Sc, MA
ragnhefr@landspitali.is
+ 354 543 6096
Backup
Halla Arnardottir, B Sc
hallarn@landspitali.is
+354 5435711
Time Frame
Start Date: 2016-01
Estimated Completion Date: 2031-05
Participants
Target number of participants: 1000
Treatments
Hepatitis C infected
All patients diagnosed with hepatitis C in Iceland
Related Therapeutic Areas
Sponsors
Leads: Landspitali University Hospital
Collaborators: National Center of Addiction Medicine (SAA)